No link has been established with denture wearing, chemical or physical trauma, or tobacco use
In this context, prioritizing treatment for high-risk groups such as individuals with advanced fibrosis, multiple cardiometabolic comorbidities, or rapid disease progression may offer the greatest clinical benefit
143 subjects were included in the final analysis (n=73 in the intervention group, n=70 in the control)
Conclusion GLP-1 weight loss clinical trials offer a unique opportunity to explore promising treatments for obesity
Several large studies using electronic health records and insurance claims data have tracked people using GLP-1 medications for five years or more
Together, youll review your medical history and finalize your prescription